Send to:

Choose Destination
See comment in PubMed Commons below
Mov Disord. 2007;22 Suppl 18:S476-84.

Augmentation as a treatment complication of restless legs syndrome: concept and management.

Author information

  • 1Sleep Research Institute, Alberto Alcocer 19, 28036 Madrid, Spain.

Erratum in

  • Mov Disord. 2008 Jun;23(8):1200-2.


Augmentation constitutes the main complication of long-term dopaminergic treatment in restless legs syndrome (RLS). Although this condition was first described in 1996, and is characterized by an overall increase in severity of RLS symptoms (including earlier onset of symptoms during the day, faster onset of symptoms when at rest, expansion to the upper limbs and trunk, and shorter duration of the treatment effect), precise diagnostic criteria were not established until 2003. These criteria have recently been updated to form a new definition of augmentation based on multicentric studies. The present article reviews our current knowledge on clinical diagnosis, evaluation, pathophysiology, and treatment recommendations for this condition.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk